Navigation Links
E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market
Date:11/26/2007

to automatic posting of the report to the RIS system without a manual fax, email or data re-entry."

The MEDxConnect System acts as a communications hub, enabling various PACS, HIS, RIS and other data information systems to connect and communicate across the Enterprise. Utilizing HL7, DICOM, and other standards, the System helps control the flow of images, reports, messages, standard patient demographics and other important data for diagnosis and treatment planning of a patient between otherwise independent and disparate systems.

The integrated imaging and data management solution from Compressus is designed to support a facility's current and expanded workload and provide an infrastructure for sustained growth. Building the functionality required for remote connectivity, the system enables users to access diagnostic images and reports in the existing data stores at each facility, increasing the level of medical care while reducing the associated costs.

"The Compressus technology gives us the opportunity to maximize the workflow of the radiologists we engage and provide premium services customized to our clients' needs," said Stuart Gardner, chief technology officer of E-Rad Solutions.

According to Dr. Gonwa, to successfully build a complete and flexible system to efficiently manage the diagnostic and reporting radiological services for their clients from multiple referring organizations, the implementation had to address the many complexities unique to the teleradiology industry. These include the ability to retrieve and store diagnostic images on DICOM archives, the ability to manage their activities via a patient work list generated from multiple PACS or network systems, and the ability to route images to participating physicians based upon any combination of modality, body part, and/or referring physician. Finally, to maximize productivity and reduce spikes in workload, physicians have the ability to access patients work lists througho
'/>"/>

SOURCE Compressus Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
2. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
3. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
4. BioLife Solutions Expands Scientific Advisory Board
5. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
6. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
7. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
8. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
9. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
10. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
11. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: EMDY), a leading,producer and distributor of infant and children,s formul
(Date:12/2/2009)The Scientist, a leading scientific magazine covering the life sciences, ranked Photometrics’ Evolve “Intelligent” EMCCD camera fourth among the publication’s “Top 10 Inn
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Dutch Biotech Company Pepscan Appoints New CEO 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
..., March 12 Micromet, Inc. (Nasdaq: MITI ), a bi...ary antibodies for the treatment of cancer, inflam...at it is regaining from its partner MedImmune the ...antibody candidate, blinatumomab, also known as MT...linical trial with blinatumomab for the treatment ...
... 12 Albert Liou, Corporate Vice President and Gen...national Corporation (Nasdaq: PRXL ), a leading ...resent "The True Value of Incorporating Asia into ...Medical Asia 2009 conference, to be held March 16 ...onvention & Exhibition Centre in Singapore. Mr...
...nds to acquire all outstanding shares of Genentech...nd early development to operate as an independent ...rters of combined U.S. commercial operations; Gene...novation will be enhanced through a diversity of r..., partnerships and other key assets , , -- Transa...
Other Biology Technology:Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 2Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 3Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 4Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 5Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 6Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 7Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 8Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 9Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 10Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 11Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 12PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009 2PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009 3PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009 4Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 2Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 3Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 4Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 5Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 6Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation 7
(Date:12/2/2009)PHILADELPHIA Mexican-American adolescents exposed to cigarette smoking scenes in movies are more likely to pick up the habit themselves, and this may be part of the acculturation process associated w
(Date:12/2/2009)PHILADELPHIA Assurance of a cancer-free status did not prompt people participating in a long-term computerized tomography (CT) lung-cancer screening program to pick up their cigarettes again, researc
(Date:12/2/2009)Recalls of ground beef, peanut butter, and other foods have done more than raise public awareness and concern about food safety. They also are quietly fueling a boom in the market for food testing equ
Breaking Biology News(10 mins):Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Ligon Discovery Announces Appointment of Errol B De Souza as Executive Chairman 6480 1Ligon Discovery Announces Appointment of Errol B De Souza as Executive Chairman 6480 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 6476 1NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 6476 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 6476 3Burnout and mental distress strongly related to errors by US surgeons 61962 1Burnout and mental distress strongly related to errors by US surgeons 61962 2
...rial suggests that long-term use of candesartan, a...gnificantly reduce the symptoms of genetic heart d... effects of candesartan on left ventricular hypert... cardiomyopathy: a pilot, randomized study," appea...ar Diagnostics . , Hypertrophic cardiomyopathy, o...
...ered that grazing animals such as deer and rabbits...drupling its prevalence in some cases and encoura...ore than 20 million acres of native grasslands in ...ad been predicted by other theories, which had sug... contain or reduce disease. They point once again ...
... emerging field of nutrigenomics, which aims to i...y,s response to diet and studies how the bioactive...xplored in a series of provocative, interdisciplin...ial Issue (Volume 12, number 4) of OMICS: A Journ...l published by Mary Ann Liebert, Inc. ( www.lieber...
Other Biology News:Grazing animals help spread plant disease 2Nutrigenomics -- developing personalized diets for disease prevention 2
...Flow Perm/Wash Buffer I can be used in intracellul...ling proteins to permeabilize cells and to serve a...e saponin-mediated cell permeabilization is a reve...in the presence of saponin during intracellular st...
Mouse Anti-Human PREB Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human ACTN4 Monoclonal Antibody, Unconjugated, Clone 4D10 from Abnova Corporation
...iendly Eppendorf Thermomixer R offers maximum appl...equire shaking, heating, and cooling. Its active h...pplication and temperature control ranges. Five di...4 micro test tubes, are available for: 0.5 ml, 1.5...
Biology Products: